Objective: To explore the associations of single-nucleotide polymorphisms (SNPs) of the C-reactive protein (CRP), interleukin 6 (IL-6) and IL-10 genes with susceptibility and severity of community-acquired pneumonia (CAP). Materials and Methods: Two hundred seventy-nine CAP patients were selected for the case group and 156 healthy individuals for the control group. Polymerase chain reaction-restriction fragment length polymorphism was performed for genotyping of CRP +1059G/C (rs1800947) and +1846C/T (rs1205), IL-6 −597G/A (rs1800797) and −572C/G (rs1800796), and IL-10 −592C/A (rs1800872) and −1082G/A (rs1800896). According to CURB-65 score, the patients were assigned into the severe community-acquired pneumonia (SCAP) and non-SCAP groups. Results: The frequencies of the CRP +1846C/T (rs1205) (CT+TT) genotypes and T allele, the IL-6 −597G/A (rs1800797) (AA+AG) genotypes and A allele, and the IL-10 −592C/A (rs1800872) (CA+AA) genotypes and A allele were higher in the case group than the control group. Furthermore, the frequencies of the CRP +1846C/T (rs1205) (CT+TT) genotypes and T allele, the IL-6 −597G/A (rs1800797) A allele, and the IL-10 −592C/A (rs1800872) (CA+AA) genotypes and A allele were higher in the SCAP group than in the non-SCAP group. Conclusion: The CRP +1846C/T (rs1205), IL-6 −597G/A (rs1800797), and IL-10 −592C/A (rs1800872) may be associated with the susceptibility and severity of CAP.
Get full access to this article
View all access options for this article.
References
1.
AlmirallJ, BolibarI, ToranP, et al. (2004) Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest, 125:1335-1342.
2.
AndrijevicI, MatijasevicJ, AndrijevicL, et al. (2014) Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia. Ann Thorac Med, 9:162-167.
3.
BacciMR, LemeRC, ZingNP, et al. (2015) IL-6 and TNF-alpha serum levels are associated with early death in community-acquired pneumonia patients. Braz J Med Biol Res, 48:427-432.
4.
CaoH, HegeleRA (2000) Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet, 45:100-101.
5.
ChalmersJD, SinganayagamA, HillAT (2008) C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med, 121:219-225.
6.
ChenSY, ChenCH, HuangYC, et al. (2010) Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population. Ren Fail, 32:1172-1176.
7.
ChengCW, ChienMH, SuSC, et al. (2013) New markers in pneumonia. Clin Chim Acta, 419:19-25.
8.
ChiangTY, YuYL, LinCW, et al. (2013) The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia. Clin Chim Acta, 424:261-266.
9.
DanH, LeiW, ChenM, et al. (2014) Essential role of IL-10/STAT3 in chronic stress-induced immune suppression[J]. Brain Behav Immun, 36:118-127.
10.
FischerCP (2006) Interleukin-6 in acute exercise and training: what is the biological relevance?. Exerc Immunol Rev, 12:6-33.
11.
GlynnP, CoakleyR, KilgallenI, et al. (1999) Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax, 54:51-55.
12.
GonzalezC, JohnsonT, RolstonK, et al. (2014) Predicting pneumonia mortality using CURB-65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center. Cancer Med, 3:962-970.
13.
KimKW, LeeKE, HongJY, et al. (2011) Involvement of IL-10 gene promoter polymorphisms in the susceptibility for childhood asthma. Lung, 189:417-423.
14.
LengS, XueQL, HuangY, et al. (2005) Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci, 60:195-199.
15.
MenendezR, MartinezR, ReyesS, et al. (2009) Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax, 64:587-591.
16.
MinamiyaY, MiuraM, HinaiY, et al. (2010) The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer. Tumour Biol, 31:673-679.
17.
MotoyamaS, MiuraM, HinaiY, et al. (2009) CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann Surg Oncol, 16:2479-2485.
18.
NiedermanMS, MandellLA, AnzuetoA, et al. (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med, 163:1730-1754.
19.
PaatsMS, BergenIM, HanselaarWE, et al. (2013) Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia. Eur Respir J, 41:1378-1385.
20.
PatwariPP, O'CainP, GoodmanDM, et al. (2008) Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr Crit Care Med, 9:553-559.
21.
PflugMA, TiutanT, WesemannT, et al. (2015) Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score. Postgrad Med J, 91:77-82.
RizzelloV, LiuzzoG, GiannuarioGD, et al. (2007) 1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina. Coron Artery Dis, 18:533-538.
24.
SaxenaM, AgrawalCG, SrivastavaN, et al. (2014) Interleukin-6 (IL-6) −597 A/G (rs1800797) & −174 G/C (rs1800795) gene polymorphisms in type 2 diabetes. Indian J Med Res, 140:60-68.
25.
ShihCM, LeeYL, ChiouHL, et al. (2005) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer, 50:291-297.
26.
SiemesC, VisserLE, CoeberghJW, et al. (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam study. J Clin Oncol, 24:5216-5222.
27.
Sole-ViolanJ, de CastroF, Garcia-LaordenMI, et al. (2010) Genetic variability in the severity and outcome of community-acquired pneumonia. Respir Med, 104:440-447.
28.
ThalmaierD, DambacherJ, SeidererJ, et al. (2006) The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment Pharmacol Ther, 24:1105-1115.
29.
VelezDR, FortunatoSJ, WilliamsSM, et al. (2008) Interleukin-6 (IL-6) and receptor (IL6-R) gene haplotypes associate with amniotic fluid protein concentrations in preterm birth. Hum Mol Genet, 17:1619-1630.
30.
VilluendasG, San MillanJL, SanchoJ, et al. (2002) The −597 G—>A and −174 G—>C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab, 87:1134-1141.
31.
WattanathumA, ManochaS, GroshausH, et al. (2005) Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest, 128:1690-1698.
32.
WuJ, JinYU, LiH, et al. (2015) Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia. Exp Ther Med, 10:175-180.
33.
WunderinkRG, WatererGW (2005) Genetics of community-acquired pneumonia. Semin Respir Crit Care Med, 26:553-562.
34.
ZhengXY, GuanWJ, MaoC, et al. (2014) Interleukin-10 promoter 1082/-819/-592 polymorphisms are associated with asthma susceptibility in Asians and atopic asthma: a meta-analysis. Lung, 192:65-73.
